Dr. Erin Savner Beck, MD

Dr. Beck practices at Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida.

Dr. Beck's NPI, 1326305293, was assigned on April 17, 2012. Dr. Beck graduated from Vagelos College of Physicians and Surgeons in 2012. Dr. Beck holds New York license 310861.

Dr. Beck's primary practice is Mount Sinai Medical Center, at 4300 Alton Rd, Miami Beach, FL 33140 in Miami-Dade County. The practice phone is (305) 674-2121. Dr. Beck also practices at Mount Sinai Medical Center, 5 E 98th St, New York, NY 10029.

Dr. Beck's primary practice is Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida. Dr. Beck is also affiliated with The Mount Sinai Hospital. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Beck to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Beck practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Beck's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Beck is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Beck's licenses on file in 3 states: New York, Florida and Maryland.

Dmand AI lists multiple sclerosis among the conditions Dr. Beck treats.

CMS data shows 84 Medicare services from Dr. Beck across 3 procedure codes in 2024, for 62 Medicare patients. Medicare paid $7,994 for them.

CMS counts 62 Medicare patients who saw Dr. Beck in 2024. The largest group is 65 to 74, with 21 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 47% are also on Medicaid. Their average risk score is 3.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Beck's median patient age at 48, with 67% women.

In 2024, Dr. Beck wrote 69 Medicare Part D claims for 13 patients. 96% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $1,058 in total drug cost. In 2022, CMS named 26 claims across 2 drugs.

Dr. Beck accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Beck as offering telehealth.

Dmand AI links 59 papers to Dr. Beck, published from 2012 to 2025. 2023 was the busiest year, with 11. The most frequent topics are Magnetic Resonance Imaging, Multiple Sclerosis and Brain. Dr. Beck has published most often in medRxiv. Dr. Beck's most frequent co-authors are Irene Claudia Maria Cortese, MD, Daniel Mendel Harrison, MD and Pawel Juliusz Muranski, MD.

Dmand AI links Dr. Beck to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Neuromyelitis Optica and Myelitis, Transverse.

CMS Open Payments shows 2 general payments to Dr. Beck from 2 drug and device companies from 2023 to 2024. Food and beverage make up the largest share, 100% of the total. Biogen, Inc. paid the most, $92.

Dr. Beck graduated from Vagelos College of Physicians and Surgeons in 2012.

Dr. Beck is in network with 16 carriers, including Aetna, United Healthcare and HCSC. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.